Since CAIX overexpression is the generally accepted sequela of hypoxia-induced HIF-1α activation [41], our results strengthen the notion that the overexpression of HIF-1α in primary ER + breast cancer may be largely hypoxia-independent. The gene discussed is HIF1A; the disease is breast cancer.